BCWORLD PHARM. Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.37%

BCWORLD PHARM. Co. Ltd (200780) has an Asset Resilience Ratio of 2.37% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BCWORLD PHARM. Co. Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩4.13 Billion

≈ $2.80 Million USD Cash + Short-term Investments

Total Assets

₩173.79 Billion

≈ $117.78 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how BCWORLD PHARM. Co. Ltd's Asset Resilience Ratio has changed over time. See 200780 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down BCWORLD PHARM. Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is BCWORLD PHARM. Co. Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩4.13 Billion	2.37%
Total Liquid Assets	₩4.13 Billion	2.37%

Asset Resilience Insights

Limited Liquidity: BCWORLD PHARM. Co. Ltd maintains only 2.37% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

BCWORLD PHARM. Co. Ltd Industry Peers by Asset Resilience Ratio

Compare BCWORLD PHARM. Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Novartis AG SW:NOVN	Drug Manufacturers - General	10.04%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.03%
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	Drug Manufacturers - General	6.44%
Korean Drug Co. Ltd KQ:014570	Drug Manufacturers - General	12.77%
SANOFI CONS HEALTHC IND L NSE:SANOFICONR	Drug Manufacturers - General	0.07%

Annual Asset Resilience Ratio for BCWORLD PHARM. Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for BCWORLD PHARM. Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.49%	₩7.91 Billion ≈ $5.36 Million	₩176.31 Billion ≈ $119.48 Million	-1.58pp
2023-12-31	6.06%	₩11.16 Billion ≈ $7.57 Million	₩184.11 Billion ≈ $124.77 Million	+1.66pp
2022-12-31	4.40%	₩8.06 Billion ≈ $5.46 Million	₩183.05 Billion ≈ $124.05 Million	+1.89pp
2021-12-31	2.51%	₩4.50 Billion ≈ $3.05 Million	₩179.36 Billion ≈ $121.55 Million	-4.00pp
2020-12-31	6.51%	₩12.56 Billion ≈ $8.51 Million	₩192.96 Billion ≈ $130.77 Million	+4.51pp
2019-12-31	2.00%	₩3.46 Billion ≈ $2.34 Million	₩172.78 Billion ≈ $117.09 Million	-0.95pp
2018-12-31	2.95%	₩4.77 Billion ≈ $3.23 Million	₩161.74 Billion ≈ $109.61 Million	-1.46pp
2017-12-31	4.41%	₩5.22 Billion ≈ $3.54 Million	₩118.34 Billion ≈ $80.20 Million	+1.70pp
2016-12-31	2.71%	₩2.61 Billion ≈ $1.77 Million	₩96.42 Billion ≈ $65.34 Million	--

pp = percentage points

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$30.55 Million

₩45.09 Billion KRW

Market Cap Rank

#23644 Global

#1696 in Korea

Share Price

₩4410.00

Change (1 day)

-0.79%

52-Week Range

₩4210.00 - ₩5870.00

All Time High

₩30700.49